Tandem Capital Management Corp Vertex Pharmaceuticals Inc Transaction History

Tandem Capital Management Corp

  • $165 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$225.48 - $295.8 $668,548 - $877,047
-2,965 Closed
0 $0
Q1 2020

May 12, 2020
SELL
$199.77 - $247.81 $5,993 - $7,434
-30 Reduced 1.0%
2,965 $706,000
Q4 2019

Mar 04, 2020
BUY
$166.71 - $223.91 $499,296 - $670,610
2,995 New
2,995 $656,000

Others Institutions Holding VRTX

# of Institutions
1,624
Shares Held
222M
Call Options Held
1.35M
Put Options Held
1.49M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Tandem Capital Management Corp Portfolio

Follow Tandem Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tandem Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Tandem Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email